Gonorrhea is a very common sexually transmitted disease (STD) caused by the bacteria Neisseria gonorrhea. It is estimated that 820,000 new cases of gonorrhea are diagnosed in the U.S. every year.
Gonorrhea is usually transmitted during vaginal, oral or anal sex or through sharing sex aids that have not been washed or covered with a condom each time they are used. A mother can also pass the infection onto her baby during childbirth, which can cause blindness in the infant.
Common symptoms in men include a burning sensation when urinating and a white, yellow, or green discharge from the penis, although some men may have no symptoms. Women with gonorrhea do not usually have any symptoms but initial symptoms may include pain or burning on urination, increased vaginal discharge, vaginal bleeding between periods and abdominal and pelvic pain.
If a woman is left untreated, infection can spread into the womb and fallopian tubes causing pelvic inflammatory disease which can lead to infertility and an increased risk for ectopic pregnancy. In men, the disease can cause epididymitis, a painful swelling in the back of the testicles that can also eventually lead to infertility.
Gonorrhea is identified using a urine test or swabs taken from a man’s urethra or a woman’s cervix. Antibiotics can be used to stop infection but cannot repair any permanent damage caused by the disease.
Self-collected tests performed similarly to provider-collected tests for detecting common sexually transmitted infections (STIs), according to research presented today at the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo. These findings could enable discreet new testing options that expand access to screening.
According to scientists from the Georgia State University’s Institute for Biomedical Sciences, producing a mutation that impedes the way the bacterial pathogen Neisseria gonorrhoeae transmits gonorrhea might provide a novel means to prevent and treat the disease.
According to psychologists, in addition to our physiological immune system, we also have a behavioral one: an unconscious code of conduct that helps us stay disease-free, including fear and avoidance of unfamiliar - and so possibly infected - people.
Professor Frédéric Veyrier of the Institut national de la recherche scientifique (INRS) has received $711,450 from the Canadian Institutes of Health Research (CIHR) for a project on bacteria of the nasopharynx, including Neisseria.
Synthetic cannabidiol, commonly called CBD, has been demonstrated to destroy the bacteria that cause meningitis, gonorrhea, and Legionnaires’ disease.
A test designed by UCLA researchers can pinpoint which people with gonorrhea will respond successfully to the inexpensive oral antibiotic ciprofloxacin, which had previously been sidelined over concerns the bacterium that causes the infection was becoming resistant to it.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.